FindTrial
Sign In

Comparison of prognosis between intraoperative cell salvage and allogeneic transfusion for operation patients

Comparison of prognosis between intraoperative cell salvage and allogeneic transfusion for operation patients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OCC-15006016
Enrollment
Unknown
Registered
2014-10-29
Start date
2015-03-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hemorrhage

Interventions

1:cell salvage
2:allogeneic transfusion

Sponsors

Department of Anesthesiology of the First Affiliated Hospital of Zhengzhou University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 80 Years

Inclusion criteria

Inclusion criteria: ASA I~II or ASA III with stable condition operation patients with expected more than 20% bleeding of the blood volume during the surgery

Exclusion criteria

Exclusion criteria: ASA 4-6 patients;non operation patients

Design outcomes

Primary

MeasureTime frame
complications;—

Secondary

MeasureTime frame
Hemoglobin;coagulation function;blood gas analysis;postoperative delirium;hospital days;cost;—

Countries

China

Contacts

Public ContactZhang Wei
zhangw571012@126.com+86 13673996966

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026